Meng-Yun Chou

1.2k total citations
7 papers, 923 citations indexed

About

Meng-Yun Chou is a scholar working on Immunology, Molecular Biology and Neurology. According to data from OpenAlex, Meng-Yun Chou has authored 7 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Meng-Yun Chou's work include Atherosclerosis and Cardiovascular Diseases (5 papers), Cellular transport and secretion (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Meng-Yun Chou is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (5 papers), Cellular transport and secretion (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Meng-Yun Chou collaborates with scholars based in United States, Austria and Germany. Meng-Yun Chou's co-authors include Joseph L. Witztum, Karsten Hartvigsen, Peter X. Shaw, Christoph J. Binder, Lotte F. Hansen, Maripat Corr, Linda Fogelstrand, Jeom‐Il Choi, Sohvi Hörkkö and Yury I. Miller and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Meng-Yun Chou

7 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meng-Yun Chou United States	7	540	221	193	152	132	7	923
Takako Ohsawa Japan	14	117 0.2×	444 2.0×	207 1.1×	48 0.3×	90 0.7×	34	1.1k
Toru Wakioka Japan	10	449 0.8×	820 3.7×	50 0.3×	55 0.4×	131 1.0×	12	1.5k
Shiming Ye United States	8	362 0.7×	191 0.9×	33 0.2×	29 0.2×	42 0.3×	12	869
B. Blanchard France	8	200 0.4×	222 1.0×	81 0.4×	49 0.3×	49 0.4×	8	547
Kanta Miyoshi Japan	5	249 0.5×	459 2.1×	38 0.2×	40 0.3×	76 0.6×	5	841
Kent Z.Q. Wang United States	12	167 0.3×	746 3.4×	104 0.5×	109 0.7×	38 0.3×	15	960
Aparna Shetty United States	6	400 0.7×	205 0.9×	82 0.4×	39 0.3×	27 0.2×	10	739
Yoshio Yazaki Japan	15	171 0.3×	483 2.2×	21 0.1×	77 0.5×	139 1.1×	26	912
D Flavell United Kingdom	11	266 0.5×	451 2.0×	24 0.1×	74 0.5×	87 0.7×	11	957
Sean Garrison United States	10	135 0.3×	595 2.7×	40 0.2×	149 1.0×	101 0.8×	13	970

Countries citing papers authored by Meng-Yun Chou

Since Specialization

Citations

This map shows the geographic impact of Meng-Yun Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Yun Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Yun Chou more than expected).

Fields of papers citing papers by Meng-Yun Chou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Yun Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Yun Chou. The network helps show where Meng-Yun Chou may publish in the future.

Co-authorship network of co-authors of Meng-Yun Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Meng-Yun Chou. A scholar is included among the top collaborators of Meng-Yun Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-Yun Chou. Meng-Yun Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mir, Rafeeq, Francesca Tonelli, Paweł Lis, et al.. (2018). The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Biochemical Journal. 475(11). 1861–1883. 141 indexed citations

2.

Lis, Paweł, Sophie Burel, Martin Steger, et al.. (2017). Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase. Biochemical Journal. 475(1). 1–22. 96 indexed citations

3.

Gonen, Ayelet, Lotte F. Hansen, William W. Turner, et al.. (2014). Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine. Journal of Lipid Research. 55(10). 2137–2155. 44 indexed citations

4.

Tsimikas, Sotirios, Atsushi Miyanohara, Karsten Hartvigsen, et al.. (2011). Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression. Journal of the American College of Cardiology. 58(16). 1715–1727. 91 indexed citations

5.

Sun, Jiusong, Karsten Hartvigsen, Meng-Yun Chou, et al.. (2010). Deficiency of Antigen-Presenting Cell Invariant Chain Reduces Atherosclerosis in Mice. Circulation. 122(8). 808–820. 74 indexed citations

6.

Chou, Meng-Yun, Linda Fogelstrand, Karsten Hartvigsen, et al.. (2009). Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. Journal of Clinical Investigation. 119(5). 1335–1349. 365 indexed citations

7.

Hartvigsen, Karsten, Meng-Yun Chou, Lotte F. Hansen, et al.. (2008). The role of innate immunity in atherogenesis. Journal of Lipid Research. 50. S388–S393. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact